DC7656 |
Ro 61-8048
Featured
|
Ro 61-8048 is a potent and competitive kynurenine 3-hydroxylase inhibitor (Ki = 4.8 nM, IC50 = 37 nM). |
|
DC70126 |
GSK 366 |
A novel potent kynurenine-3-monooxygenase (KMO) inhibitor with IC50 of 2.3 nM and 0.7 nM for human KMO and Pf-KMO, respectively. |
|
DC70127 |
GSK 065 |
A novel potent kynurenine-3-monooxygenase (KMO) inhibitor with IC50 of 4.5 nM. |
|
DC70449 |
GSK180 |
GSK180 (GSK-180) is a potent and specific inhibitor of kynurenine-3-monooxygenase (KMO) with IC50 of 6 nM, shows negligible activity against other enzymes on the tryptophan pathway; inhibits the convertion of kynurenine to 3-hydroxykynurenine with IC50 of 2.0 uM in cell-based assays; prevents multiple organ failure in rodent models of acute pancreatitis. |
|